Scarica l'app Stockscreener
0.5975
1.35%
-0.0082
Precedente Chiudi:
$0.6057
Aprire:
$0.6
Volume 24 ore:
302.99K
Relative Volume:
0.99
Capitalizzazione di mercato:
$10.45M
Reddito:
-
Utile/perdita netta:
$1.24B
Rapporto P/E:
0.0235
EPS:
25.475
Flusso di cassa netto:
$-31.80M
1 W Prestazione:
-25.92%
1M Prestazione:
-60.69%
6M Prestazione:
-96.68%
1 anno Prestazione:
-96.13%
Intervallo 1D:
$0.58
$0.62
Intervallo di 1 settimana:
$0.57
$0.85
Portata 52W:
$0.57
$27.15
Enlivex Ltd Stock (ENLV) Company Profile
Compare ENLV vs VRTX, REGN, MRNA, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Ltd
|
0.5975 | 10.45M | 0 | 1.24B | -31.80M | 25.48 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Enlivex Ltd Stock (ENLV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-03-02 | Reiterato | H.C. Wainwright | Buy |
Enlivex Ltd Borsa (ENLV) Ultime notizie
RAIN Token: Enlivex Terminates Its Financing - cryptoticker.io
Enlivex Posts Massive H1 2026 Profit on Surging Digital Asset Holdings - TipRanks
No operating revenue, yet Enlivex Ltd. (NASDAQ: ENLV) posted a first-half profit. - Stock Titan
Enlivex Therapeutics stock reports cancelled financing - AD HOC NEWS
Enlivex terminates securities deal with Rain Foundation By Investing.com - Investing.com Canada
Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement - TipRanks
Enlivex terminates securities deal with Rain Foundation - Investing.com
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens - The Manila Times
Crypto token stock sale is dropped at Enlivex (NASDAQ: ENLV) - Stock Titan
A planned 66.7 million-share sale is off. Enlivex will not seek approval. - Stock Titan
Enlivex Therapeutics stock gains on upcoming Q1 2026 earnings and steep year-to-date decline - AD HOC NEWS
Price to earnings forward of Enlivex Ltd. – FWB:1BT - tradingview.com
Enlivex Therapeutics Ltd.ADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - finance.yahoo.com
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Stock Price, News & Analysis - kalkine.ca
Enlivex (ENLV) Shares Slide 8.5% as Biotech Tests Key Support at $1.28Support Level Bounce - vinanet.vn
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Enlivex Ltd expected to post a loss of 31 cents a shareEarnings Preview - TradingView
Enlivex Therapeutics (Ondo Tokenized) - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) to Euro Price Today | Live ENLVon to EUR Converter & Exchange Rate - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) Price | ENLVon Price Today, Live Chart, USD converter, Market Capitalization - CryptoRank
Historical Data for Enlivex Therapeutics (Ondo Tokenized) in USD - CryptoRank
Enlivex Therapeutics (Ondo Tokenized) Analytics - CryptoRank
Enlivex (ENLV) Shares Drop 6.51% to $1.58 as Stock Tests Key $1.50 SupportDealer Gamma - vinanet.vn
ENLV Q4 2025 Earnings: Loss of -$117.75 Per Share Massively Misses -$0.459 Estimate; Shares Slip 6.51%New Analyst Coverage - Vinanet
Enlivex Ltd. SEC Filing (Aug 14, 2026) - Stock Titan
Enlivex Ltd. (ENLV) sees 9.99% stake reported via convertible note - Stock Titan
Enlivex Restructures $19.2 Million Convertible Note With Lind, Easing Default Risk - TipRanks
Enlivex (ENLV) revises $21M secured convertible note, adds 10% interest trigger - Stock Titan
Enlivex Therapeutics Ltd (ENLV) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
ENLV Stockholders Plan Sale of 10 Million Shares Amidst Challenging Valuation Landscape - GuruFocus
Enlivex Ltd. (NASDAQ: ENLV) files to register 10M shares for noteholder resale - Stock Titan
Enlivex (ENLV) Climbs 3.83% to $2.17 as Shares Press Against $2.28 ResistanceVolume Spike Alerts - dars.gov.et
ENLV Maintained by HC Wainwright & Co. -- Price Target Raised to $80 - GuruFocus
H.C. Wainwright Lifts Enlivex Therapeutics (ENLV) Price Target t - GuruFocus
H.C. Wainwright raises Enlivex stock price target to $80 on token gains - Investing.com
Weekly Recap: HC Wainwright & Co. PT hike and Rain Foundation financing - TradingView
ENLV Q4 2025 Earnings: Reported EPS of -117.75 Vastly Misses Estimate, Stock Rises 7.18%Share Repurchase Impact - dars.gov.et
Enlivex Therapeutics Ltd (ENLV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Enlivex Highlights 622% Surge in Rain Protocol Trading Volume to $860 Million - TipRanks
Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June - marketscreener.com
Enlivex (Nasdaq: ENLV) Rain protocol volume hits $860M, up 622% - Stock Titan
Enlivex Ltd. Revenue Breakdown – NASDAQ:ENLV - TradingView
Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones - marketscreener.com
Enlivex to Brief Investors on Private Placement, Rain Treasury Strategy and Allocetra RMAT Milestone - TipRanks
Enlivex Ltd. announced that it expects to receive $400 million in funding - marketscreener.com
Enlivex prices USD 400 million private placement at USD 5 per share - Bitget
Enlivex: Price Is $5/Shr for Subscription Amounts Funded in U.S. Dollars, USDT or USD Coin >ENLV - Moomoo
ENLV Stock Slides Into 1-For-15 Reverse Split On Nasdaq - StocksToTrade
Enlivex (ENLV) Secures $400M Private Placement at Premium Pricing - GuruFocus
Enlivex Secures $400 Million Premium-Priced Private Placement Backed by RAIN Tokens - TipRanks
Enlivex Ltd Azioni (ENLV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):